Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11549624 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
Conditions: Pre-diabetes;   Type 2 Diabetes
Interventions: Drug: Exenatide;   Drug: Sitagliptin;   Drug: Glimepiride

Indicates status has not been verified in more than two years